Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application and validation of AI-assisted 3D-Printed gastroduodenal anatomical variation models in specialized nursing training.

Frontiers in bioengineering and biotechnology·2026
Same author

Engineered cell-biomimetic nanosystems for anti-inflammatory therapy: Targeting, neutralization and immunomodulation.

Acta pharmaceutica Sinica. B·2026
Same author

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

Analytical biochemistry·2026
Same author

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same journal

Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases.

Cell death & disease·2026
Same journal

The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development.

Cell death & disease·2026
Same journal

Activation of KIT signaling promotes early tumorigenesis through the AP-1 pathway in APC/TP53 double-knockout human colon organoids.

Cell death & disease·2026
Same journal

Rethinking LPCAT3 roles in human disease: broadening perspectives beyond ferroptosis.

Cell death & disease·2026
Same journal

GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m<sup>6</sup>A-METTL14-YTHDF2 axis, attenuating glioblastoma progression.

Cell death & disease·2026
Same journal

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Cell death & disease·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.1K

Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis.

Wenbo Zhou1, Michael Graner1, Petr Paucek1

  • 1Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.

Cell Death & Disease
|April 8, 2023
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) plasma immunoglobulin G (IgG) forms large aggregates that induce significant neuronal apoptosis, a key factor in MS neurodegeneration and axonal damage.

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.6K
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K

Related Experiment Videos

Last Updated: Jun 28, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.1K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.6K
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K

Area of Science:

  • Neuroimmunology
  • Pathology
  • Molecular Biology

Background:

  • Grey matter pathology drives multiple sclerosis (MS) progression.
  • The specific mechanisms of neurodegeneration in MS are under investigation.

Purpose of the Study:

  • To investigate the role of MS plasma immunoglobulin G (IgG) aggregates in neuronal apoptosis.
  • To elucidate the link between MS IgG aggregates, complement activation, and neurodegeneration.

Main Methods:

  • Annexin V apoptosis assay to quantify neuronal cell death.
  • Analysis of MS plasma IgG aggregates using transmission electron microscopy and nanoparticle tracking.
  • Evaluation of complement activation products (C1q, C3b, C5b9) and caspase 3 in neuronal cells.
  • Inhibition studies using IgG depletion, IdeS enzyme, and caspase inhibitors.

Main Results:

  • MS plasma IgG forms aggregates (>100 nm) that induce six times higher neuronal apoptosis compared to controls.
  • MS IgG aggregates trigger complement-dependent neuronal apoptosis, evidenced by co-deposition of IgG, complement components, and active caspase 3.
  • Neuronal apoptosis is mediated by IgG aggregates and can be inhibited by IgG depletion, IdeS digestion, or caspase inhibition.

Conclusions:

  • MS IgG aggregates play a pathological role in neurodegeneration.
  • Complement activation by MS IgG aggregates contributes to neuronal apoptosis and axonal damage.
  • Apoptosis is a significant mechanism of neurodegeneration in multiple sclerosis.